- Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
- Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
- Allurion Announces Launch of Offering of Common Stock and Warrants
- Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
- Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
- Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
- Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
- Allurion to Participate in Two Upcoming Investor Conferences in June 2024
- Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
- Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
More ▼
Key statistics
As of last trade Allurion Technologies Inc (ALUR:NYQ) traded at 0.8209, 1.35% above its 52-week low of 0.81, set on Jul 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.87 |
---|---|
High | 0.89 |
Low | 0.812 |
Bid | 0.821 |
Offer | 0.8544 |
Previous close | 0.866 |
Average volume | 251.26k |
---|---|
Shares outstanding | 62.31m |
Free float | 50.72m |
P/E (TTM) | -- |
Market cap | 58.34m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of Jul 23 2024 16:57 BST.
More ▼